NO175476C - Analogifremgangsmåte ved fremstilling av terapeutisk aktive cykloalkyltiazolderinvater - Google Patents

Analogifremgangsmåte ved fremstilling av terapeutisk aktive cykloalkyltiazolderinvater

Info

Publication number
NO175476C
NO175476C NO892914A NO892914A NO175476C NO 175476 C NO175476 C NO 175476C NO 892914 A NO892914 A NO 892914A NO 892914 A NO892914 A NO 892914A NO 175476 C NO175476 C NO 175476C
Authority
NO
Norway
Prior art keywords
cycloalkylthiazole
derivatives
preparation
therapeutically active
analogous procedure
Prior art date
Application number
NO892914A
Other languages
English (en)
Norwegian (no)
Other versions
NO892914D0 (no
NO175476B (no
NO892914L (no
Inventor
George Francis Field
John Raymond Vermeulen
William Joseph Zally
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/366,097 external-priority patent/US5001140A/en
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of NO892914D0 publication Critical patent/NO892914D0/no
Publication of NO892914L publication Critical patent/NO892914L/no
Publication of NO175476B publication Critical patent/NO175476B/no
Publication of NO175476C publication Critical patent/NO175476C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/28Radicals substituted by nitrogen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pulmonology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO892914A 1988-07-15 1989-07-14 Analogifremgangsmåte ved fremstilling av terapeutisk aktive cykloalkyltiazolderinvater NO175476C (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US22611288A 1988-07-15 1988-07-15
US33904689A 1989-04-17 1989-04-17
US07/366,097 US5001140A (en) 1989-04-17 1989-06-13 Cycloalkylthiazoles

Publications (4)

Publication Number Publication Date
NO892914D0 NO892914D0 (no) 1989-07-14
NO892914L NO892914L (no) 1990-01-16
NO175476B NO175476B (no) 1994-07-11
NO175476C true NO175476C (no) 1994-10-19

Family

ID=27397563

Family Applications (1)

Application Number Title Priority Date Filing Date
NO892914A NO175476C (no) 1988-07-15 1989-07-14 Analogifremgangsmåte ved fremstilling av terapeutisk aktive cykloalkyltiazolderinvater

Country Status (21)

Country Link
EP (1) EP0355353B1 (fi)
JP (1) JPH0737454B2 (fi)
KR (1) KR960010352B1 (fi)
AR (1) AR247737A1 (fi)
AU (1) AU626308B2 (fi)
BG (1) BG60765B2 (fi)
CA (1) CA1333906C (fi)
CS (1) CS417291A3 (fi)
DE (1) DE68913856T2 (fi)
DK (1) DK350989A (fi)
ES (1) ES2052825T3 (fi)
FI (1) FI93953C (fi)
HU (2) HU203087B (fi)
IE (1) IE64011B1 (fi)
IL (1) IL90958A0 (fi)
MC (1) MC2049A1 (fi)
MX (1) MX9203632A (fi)
NO (1) NO175476C (fi)
NZ (1) NZ229928A (fi)
PH (1) PH27275A (fi)
PT (1) PT91179B (fi)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5273986A (en) * 1992-07-02 1993-12-28 Hoffmann-La Roche Inc. Cycloalkylthiazoles
EP0643045B1 (de) * 1993-09-10 2000-03-08 Novartis AG Chinolin-Verbindungen als Leukotriene Antagonisten
US5508408A (en) * 1993-09-10 1996-04-16 Ciba-Geigy Corporation Quinoline compound
WO1996008479A1 (en) * 1994-09-13 1996-03-21 F. Hoffmann-La Roche Ag A process of making (e)-4-[3-[2-(4-cycloalkyl-2-thiazolyl)ethenyl]phenyl]amino-2,2-alkyldiyl-4-oxobutanoic acid
WO1996027592A1 (en) * 1995-03-03 1996-09-12 F. Hoffmann-La Roche Ag Polymorphic b form of (e)-4-[[3-[2-(4-cyclobutyl-2-thiazolyl)ethenyl]phenyl]amino]-2,2-diethyl-4-oxobutanoic acid
AU5347496A (en) * 1995-04-21 1996-11-07 Daiichi Pharmaceutical Co., Ltd. Ethynylthiazole derivative

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62142168A (ja) * 1985-10-16 1987-06-25 Mitsubishi Chem Ind Ltd チアゾ−ル誘導体及びそれを有効成分とするロイコトリエンきつ抗剤

Also Published As

Publication number Publication date
FI93953B (fi) 1995-03-15
KR900001665A (ko) 1990-02-27
KR960010352B1 (ko) 1996-07-30
JPH0737454B2 (ja) 1995-04-26
HU211268A9 (en) 1995-11-28
HU203087B (en) 1991-05-28
MX9203632A (es) 1992-07-01
MC2049A1 (fr) 1990-07-17
EP0355353A2 (en) 1990-02-28
PH27275A (en) 1993-05-04
DK350989D0 (da) 1989-07-14
FI893434A0 (fi) 1989-07-14
NO892914D0 (no) 1989-07-14
FI93953C (fi) 1995-06-26
BG60765B2 (bg) 1996-02-29
PT91179B (pt) 1995-03-01
CS417291A3 (en) 1992-09-16
DE68913856D1 (de) 1994-04-21
HUT52489A (en) 1990-07-28
AU3828089A (en) 1990-01-18
PT91179A (pt) 1990-02-08
DE68913856T2 (de) 1994-10-20
FI893434A (fi) 1990-01-16
CA1333906C (en) 1995-01-10
IL90958A0 (en) 1990-02-09
AR247737A1 (es) 1995-03-31
NO175476B (no) 1994-07-11
IE892294L (en) 1990-01-15
ES2052825T3 (es) 1994-07-16
JPH0269468A (ja) 1990-03-08
EP0355353A3 (en) 1990-03-07
NZ229928A (en) 1992-08-26
DK350989A (da) 1990-01-16
IE64011B1 (en) 1995-06-28
AU626308B2 (en) 1992-07-30
EP0355353B1 (en) 1994-03-16
NO892914L (no) 1990-01-16

Similar Documents

Publication Publication Date Title
NO174101C (no) Analogifremgangsmåte ved fremstilling av terapeutisk aktive triazolderivater
NO172540C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive pyrrolderivater
NO170483C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive tetrahydronaftalin- og indanderivater
NO176796C (no) Analogifremgangsmåte ved fremstilling av terapeutisk aktive triazolderivater
NO179584C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive 2-acylaminotiazoler
NO175978C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive bis-aza-bicykliske forbindelser
NO174467C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive kromanderivater
NO170884C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive pyrimidinderivater
NO176275C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive pyridazinonderivater
NO903941D0 (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive diazepinon-derivater.
NO166083C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive pyridazodiazepinderivater.
NO165841C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive heteroaryl-3-okso-propannitril-derivater.
NO172575C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzocykloalkanderivater
NO171507C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive nukleotidderivater
NO173334C (no) Analogifremgangsm}te for fremstilling av terapeutisk aktive alkylaminoalkylenderivater 2H-1-benzopyraner
NO178069C (no) Analogifremgangsmåte ved fremstilling av terapeutisk aktive platinakomplekser
NO172489C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive imidazolderivater
NO173784C (no) Anaslogifremgangsmaate for fremstilling av terapeutisk aktive tieno-tri-azolo-diazepinderivater
NO174391C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive kromanderivater
NO174422C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive kromanderivater
NO164020C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive fenetanolaminderivater.
NO172643C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive benzopyranolderivater
NO171065C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive pyrimidinderivater
NO174203C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive
NO169007C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive uridinderivater